Almac Discovery
Almac Discovery is a research driven drug discovery company dedicated to the development of novel and innovative approaches to the treatment of diseases of unmet need (including oncology and CNS), by applying a target class approach. The Almac Discovery business model is to develop preclinical stage assets which are then licenced to pharmaceutical or biotech partners for further development. We also look to collaborate with partners to apply our medicinal chemistry and translational biology expertise to targets of mutual interest. Key research themes include deubiquitinase enzymes and protein drug conjugates.
Contact Almac Discovery via their website
News archive
18/05/2021 Almac Discovery Publishes Ground-breaking Cancer Research...more
18/01/2021 Prof Daniel Longley Joins Almac Discovery to Accelerate Colorectal Cancer Research...more
2020 Almac Discovery joins Almac Group in the BioPartner programme...more
